Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CRCA vs. CRCD: which is better?

Bottom line

CRCA vs CRCD: the short answer

CRCA (ProShares Ultra CRCL) and CRCD (T-rex 2x Inverse Crcl Daily Target ETF) are both etfs.

But CRCA is far broader, holding 11 positions to 3 for CRCD, so beyond the top names it adds exposure CRCD doesn't have.

CRCA is cheaper at 0.95% vs 1.5% — a difference of $55 a year per $10,000 invested.

Updated Nov 19, 2026

CRCA vs CRCD side by side

CRCACRCD
TypeETFETF
Fund familyProSharesSEI
CategoryOtherLeveraged & Inverse
Expense ratio0.95%1.5%
Annual cost per $10k$95$150
10-yr cost on $10k (prospectus)$1,231$1,791
Max front loadNoneNone
12b-1 fee—0%
1-yr return——
5-yr return (annualized)——
10-yr return (annualized)——
Best quarter——
Worst quarter——
Net assets (fund)$227.5M$8.6M
Number of holdings113
Portfolio turnover%%
Returns as of——

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

7 of CRCA's top 11 holdings also appear in CRCD's top 3.

Shared top holdings
HoldingCRCACRCD
N/a4.32%15.61%
N/a0.21%15.61%
N/a-2.27%15.61%
N/a-2.52%15.61%
N/a-2.98%15.61%
N/a-3.09%15.61%
N/a-4.42%15.61%

Source: SEC Form N-PORT

CRCA top 10

  1. Repurchase Agreement — 6.18%
  2. N/a — 4.32%
  3. Repurchase Agreement — 3.89%
  4. Repurchase Agreement — 2.92%
  5. Repurchase Agreement — 2.14%
  6. N/a — 0.21%
  7. N/a — -2.27%
  8. N/a — -2.52%
  9. N/a — -2.98%
  10. N/a — -3.09%

CRCD top 10

  1. N/a — 93.21%
  2. N/a — 15.61%
  3. First American Government Obli — 2.91%

FAQ

What is the difference between CRCA and CRCD?
CRCA (ProShares Ultra CRCL) and CRCD (T-rex 2x Inverse Crcl Daily Target ETF) are both etfs. But CRCA is far broader, holding 11 positions to 3 for CRCD, so beyond the top names it adds exposure CRCD doesn't have.
Which is cheaper, CRCA or CRCD?
CRCA has the lower expense ratio (0.95%).
Should I own both CRCA and CRCD?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.